Curaleaf Holdings, Inc. (CURLF) Reports Q2 Loss, Misses Revenue Estimates

Curaleaf Holdings, Inc. (CURLF) came out with a quarterly loss of $0.06 per share versus the Zacks Consensus Estimate of a loss of $0.07. This compares to a loss of $0.06 per share a year ago. These figures are adjusted for non-recurring items. Over the last four quarters, the company has surpassed consensus EPS estimates two times. Curaleaf Holdings, Inc., which belongs to the Zacks Medical - Products industry, posted revenues of $314.52 million for the quarter ended June 2025, missing the Zacks Consensus ...